![](/img/cover-not-exists.png)
PCN10 COSTS OF MANAGING TOXICITIES IN ADVANCED NON-SMALL CELL LUNG CANCER WITH PEMETREXED COMPARED WITH DOCETAXEL AS SECOND-LINE CHEMOTHERAPY
M Aristides, D Jackson, AM Liepa, NB Leighl, F ShepherdVolume:
6
Year:
2003
Language:
english
DOI:
10.1016/s1098-3015(10)61873-6
File:
PDF, 84 KB
english, 2003